SynbiCITE welcomes RebelBio to London
- Posted on 6 December, 2017
We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itself. We run a crucible that transforms scientists into entrepreneurs.
On top of our cash investment, during the program, teams have access to a fully equipped biosafety level lab, co-working space, dedicated mentorship and the support of a network of RebelBio alumni, investors, corporates and press partners.
RebelBio is an SOSV Accelerator.
Apply here: https://goo.gl/iencnF
Share this article:
People also read
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...